Nearly two-thirds of patients who started on weight-loss drugs Wegovy or Zepbound last year were still taking them a year ...

Sixty-three percent of patients starting on Novo Nordisk's Wegovy or Eli Lilly's Zepbound during the first quarter of 2024 ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

Wegovy, a weight-loss injection containing semaglutide, has arrived in India, offering a new approach to combatting obesity ...

It comes in an injectible pen and is self-administered once weekly. Wegovy should be used in conjunction with healthy lifestyle shifts, including diet and regular exercise. Wegovy vs. Ozempic ...

Another major insurance change coming next year will affect another large swath of Dushay’s patients: In January, BCBS ...

She began using Wegovy, the version of Ozempic approved for weight loss, after struggling with obesity. She reveals which ...

On this page Weight loss drugs cost an average of $1,083 per month or $12,996 per year if you pay full price without any discounts or coupons. If your insurance covers weight loss drugs like Ozempic ...

Sir Kier Starmer has set out his 10-year-plan to reform the NHS in England, based on a shift from hospitals to neighbourhood ...

Eli Lillys Mounjaro KwikPen gains approval in India, targeting diabetes and obesity with its dual-action formula for weight ...